If the medication continues to help you manage your weight effectively, therefore improving your wellness, your doctor may advise you to continue taking it as part of a long-term weight management plan
Only if your vial concentration makes 50 units equal to 5 mg

Tirzepatide tends to be the better choice if: You have a higher starting BMI (say, above 35) and want maximum weight loss You also have type 2 diabetes and need stronger glycemic control You've tried semaglutide and plateaued before reaching your goal Cost is similar for you (LillyDirect direct-pay vials currently undercut Wegovy on entry tiers) Semaglutide tends to be the better choice if: You have established cardiovascular disease and want a drug with proven CV outcome benefit (SELECT) [9] You tolerated 1 mg Ozempic well in the past and your insurance covers Wegovy You prefer the longer real-world track record (Wegovy approved 2021 versus Zepbound 2023) You need an oral option (Rybelsus, though it's FDA-approved for diabetes, not weight loss) Either is reasonable if: You're starting from BMI 30 to 35 with no major comorbidities Your insurance pushes you toward one over the other You're in the early titration period and haven't yet seen what your response looks like A real-world example

Current pricing and any active promotional offers should be verified directly through the official altRx page before enrollment
Another 2024 case study reported a man in his forties with folliculitis decalvans (FD), a rare scarring hair loss condition, saw major improvement after starting Mounjaro for weight loss
Peptide structure and folding Every peptide has a specific amino acid sequence that determines how it folds